Wharton J - Search Results

1

Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid.

Zhao L, Chen CN, Hajji N, Oliver E, Cotroneo E, Wharton J, Wang D, Li M, McKinsey TA, Stenmark KR, Wilkins MR. Zhao L, et al. Among authors: wharton j. Circulation. 2012 Jul 24;126(4):455-67. doi: 10.1161/CIRCULATIONAHA.112.103176. Epub 2012 Jun 18. Circulation. 2012. PMID: 22711276 Free PMC article.

2

Identification of renal natriuretic peptide receptor subpopulations by use of the non-peptide antagonist, HS-142-1.

Rutherford RA, Matsuda Y, Wilkins MR, Polak JM, Wharton J. Rutherford RA, et al. Among authors: wharton j. Br J Pharmacol. 1994 Nov;113(3):931-9. doi: 10.1111/j.1476-5381.1994.tb17082.x. Br J Pharmacol. 1994. PMID: 7858888 Free PMC article.

3

The natriuretic peptide family: turning hormones into drugs.

Wilkins MR, Nunez DJ, Wharton J. Wilkins MR, et al. Among authors: wharton j. J Endocrinol. 1993 Jun;137(3):347-59. doi: 10.1677/joe.0.1370347. J Endocrinol. 1993. PMID: 8371073 Review. No abstract available.

4

Downregulation of natriuretic peptide C-receptor protein in the hypertrophied ventricle of the aortovenocaval fistula rat.

Brown LA, Rutherford RA, Nunez DJ, Wharton J, Lowe DG, Wilkins MR. Brown LA, et al. Among authors: wharton j. Cardiovasc Res. 1997 Dec;36(3):363-71. doi: 10.1016/s0008-6363(97)00192-2. Cardiovasc Res. 1997. PMID: 9534857

5

Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells.

Wharton J, Davie N, Upton PD, Yacoub MH, Polak JM, Morrell NW. Wharton J, et al. Circulation. 2000 Dec 19;102(25):3130-6. doi: 10.1161/01.cir.102.25.3130. Circulation. 2000. PMID: 11120706

6

Progress in, and future prospects for, the treatment of primary pulmonary hypertension.

Wilkins MR, Wharton J. Wilkins MR, et al. Among authors: wharton j. Heart. 2001 Dec;86(6):603-4. doi: 10.1136/heart.86.6.603. Heart. 2001. PMID: 11711446 Free PMC article. No abstract available.

7

ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells.

Davie N, Haleen SJ, Upton PD, Polak JM, Yacoub MH, Morrell NW, Wharton J. Davie N, et al. Among authors: wharton j. Am J Respir Crit Care Med. 2002 Feb 1;165(3):398-405. doi: 10.1164/ajrccm.165.3.2104059. Am J Respir Crit Care Med. 2002. PMID: 11818328

8

Developments in therapeutics for pulmonary arterial hypertension.

Wilkins MR, Møller GM, Ren X, Wharton J. Wilkins MR, et al. Among authors: wharton j. Minerva Cardioangiol. 2002 Jun;50(3):175-87. Minerva Cardioangiol. 2002. PMID: 12107399 Review.

9

Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.

Wharton J, Strange JW, Møller GM, Growcott EJ, Ren X, Franklyn AP, Phillips SC, Wilkins MR. Wharton J, et al. Am J Respir Crit Care Med. 2005 Jul 1;172(1):105-13. doi: 10.1164/rccm.200411-1587OC. Epub 2005 Apr 7. Am J Respir Crit Care Med. 2005. PMID: 15817798

10

Phosphodiesterase type 5 and high altitude pulmonary hypertension.

Aldashev AA, Kojonazarov BK, Amatov TA, Sooronbaev TM, Mirrakhimov MM, Morrell NW, Wharton J, Wilkins MR. Aldashev AA, et al. Among authors: wharton j. Thorax. 2005 Aug;60(8):683-7. doi: 10.1136/thx.2005.041954. Thorax. 2005. PMID: 16061711 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

581 results

Search Page

Filters